NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRBO NeuroBo Pharmaceuticals, Inc.

盘前交易 07-22 08:50:40 EDT

4.51

+0.00

0.00%

盘前4.67

+0.16+3.55%

08:31 EDT

最高4.73	最低4.42	成交量8,799
今开4.56	昨收4.51	日振幅6.87%
总市值2,557万	流通市值61.83万	总股本566.94万
成交额4.01万	换手率6.42%	流通股本13.71万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRBO","market":"US","secType":"STK","nameCN":"NeuroBo Pharmaceuticals, Inc.","latestPrice":4.51,"timestamp":1721419200000,"preClose":4.51,"halted":0,"volume":8799,"hourTrading":{"tag":"盘前","latestPrice":4.67,"preClose":4.51,"latestTime":"08:31 EDT","volume":541,"amount":2411.950038,"timestamp":1721651467426},"delay":0,"floatShares":137100,"shares":5669400,"eps":-3.271078,"marketStatus":"盘前交易","marketStatusCode":1,"change":0,"latestTime":"07-22 08:50:40 EDT","open":4.56,"high":4.73,"low":4.42,"amount":40094.0196636,"amplitude":0.068736,"askPrice":5.31,"askSize":100,"bidPrice":4,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.271078,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721655000000},"adr":0,"listingDate":1470369600000,"adjPreClose":4.51,"preHourTrading":{"tag":"盘前","latestPrice":4.67,"preClose":4.51,"latestTime":"08:31 EDT","volume":541,"amount":2411.950038,"timestamp":1721651467426},"postHourTrading":{"tag":"盘后","latestPrice":4.51,"preClose":4.51,"latestTime":"19:43 EDT","volume":47,"amount":211.7,"timestamp":1721432594401},"volumeRatio":0.21689992469665018,"impliedVol":3.214,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/NRBO","defaultTab":"news","newsList":[{"id":"2452560864","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452560864","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452560864?lang=zh_cn&edition=full","pubTime":"2024-07-19 03:35","pubTimestamp":1721331318,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日03时35分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅跳水6.11%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.97%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3387.50%、2783.56%、1325.77%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719033518af93022c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719033518af93022c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OXM","BK4202","BK4139","NRBO"],"gpt_icon":0},{"id":"2452169436","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近午盘大幅跳水5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452169436","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452169436?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:36","pubTimestamp":1721230619,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时36分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.18%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.04%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3045.23%、1329.03%、280.54%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为76.39%、46.25%、43.75%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233659941f7f3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717233659941f7f3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","NRBO","OXM"],"gpt_icon":0},{"id":"2451744552","title":"Neurobo Pharmaceuticals, Inc.盘中异动 下午盘大幅上涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451744552","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451744552?lang=zh_cn&edition=full","pubTime":"2024-07-13 02:53","pubTimestamp":1720810422,"startTime":"0","endTime":"0","summary":"北京时间2024年07月13日02时53分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.36%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Qualigen Therapeutics, Inc.、Zura Bio Limited C/Wts 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Qualigen Therapeutics, Inc.、Soligenix, Inc.、Clearmind Medicine Inc.较为活跃，换手率分别为4073.72%、120.26%、100.83%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Xortx Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为147.88%、78.88%、65.30%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713025343af922264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240713025343af922264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","OXM","NRBO"],"gpt_icon":0},{"id":"2450360784","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450360784","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450360784?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:56","pubTimestamp":1720713381,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时56分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.06%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Neximmune, Inc.、Kazia Therapeutics Limited、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Kazia Therapeutics Limited、Neximmune, Inc.较为活跃，换手率分别为633.46%、598.97%、533.31%，振幅较大的相关个股有Neximmune, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Kazia Therapeutics Limited，振幅分别为165.58%、149.14%、93.77%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112356219681c102&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112356219681c102&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","NRBO","OXM"],"gpt_icon":0},{"id":"2450407210","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.70%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450407210","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450407210?lang=zh_cn&edition=full","pubTime":"2024-07-10 03:40","pubTimestamp":1720554056,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日03时40分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.70%。截至发稿，该股报4.35美元/股，成交量1.7891万股，换手率0.18%，振幅5.86%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710034056aef8c23c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710034056aef8c23c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4139","OXM","NRBO"],"gpt_icon":0},{"id":"2448944298","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.79%报4.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448944298","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448944298?lang=zh_cn&edition=full","pubTime":"2024-07-02 03:43","pubTimestamp":1719862985,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日03时43分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.79%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Senti Biosciences, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Senti Biosciences, Inc.、Geovax Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为833.90%、208.74%、133.68%，振幅较大的相关个股有Senti Biosciences, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Cingulate Inc.，振幅分别为101.49%、83.23%、82.81%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702034305941f2cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702034305941f2cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","OXM","BK4202","BK4139"],"gpt_icon":0},{"id":"2446556737","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446556737","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446556737?lang=zh_cn&edition=full","pubTime":"2024-06-27 22:14","pubTimestamp":1719497690,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日22时14分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.38%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.涨幅较大，Geovax Labs, Inc.、Nls Pharmaceutics Ltd.、Kala Bio, Inc.较为活跃，换手率分别为1317.83%、236.87%、231.22%，振幅较大的相关个股有Geovax Labs, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd.，振幅分别为124.57%、112.22%、79.30%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627221450941f1d53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627221450941f1d53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","OXM","NRBO"],"gpt_icon":0},{"id":"2446539611","title":"Neurobo Pharmaceuticals, Inc.盘中异动 急速拉升15.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446539611","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446539611?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:31","pubTimestamp":1719408703,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日21时31分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速拉升15.96%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Anew Medical, Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Conduit Pharmaceuticals Inc.涨幅较大，Anew Medical, Inc.、Cns Pharmaceuticals, Inc.、Gri Bio, Inc.较为活跃，换手率分别为280.96%、60.33%、58.54%，振幅较大的相关个股有Anew Medical, Inc.、Atossa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为34.21%、20.87%、19.51%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262131439f67f264&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406262131439f67f264&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4139","OXM","BK4202"],"gpt_icon":0},{"id":"2446429138","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.39%报3.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446429138","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446429138?lang=zh_cn&edition=full","pubTime":"2024-06-25 22:21","pubTimestamp":1719325270,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日22时21分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.39%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.62%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Glycomimetics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 涨幅较大，Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为169.82%、143.60%、84.80%，振幅较大的相关个股有Glycomimetics, Inc.、Effector Therapeutics, Inc.、Senti Biosciences, Inc.，振幅分别为37.88%、34.24%、33.10%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625222110941f0f30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625222110941f0f30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","NRBO","OXM"],"gpt_icon":0},{"id":"2445518072","title":"Neurobo Pharmaceuticals, Inc.股价重挫17.44% 市值跌286.78万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445518072","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445518072?lang=zh_cn&edition=full","pubTime":"2024-06-24 21:31","pubTimestamp":1719235904,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日21时31分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速下挫17.44%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Revelation Biosciences, Inc.、阿里拉姆制药涨幅较大，Revelation Biosciences, Inc.、Gri Bio, Inc.、Effector Therapeutics, Inc.较为活跃，换手率分别为261.47%、42.66%、30.54%，振幅较大的相关个股有Revelation Biosciences, Inc.、Psyence Biomedical Ltd.、G1 Therapeutics, Inc.，振幅分别为15.17%、11.62%、10.20%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242131459f60005b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406242131459f60005b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","OXM","BK4139","BK4202"],"gpt_icon":0},{"id":"2444454754","title":"Neurobo Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.15%报3.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444454754","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444454754?lang=zh_cn&edition=full","pubTime":"2024-06-19 02:50","pubTimestamp":1718736652,"startTime":"0","endTime":"0","summary":"北京时间2024年06月19日02时50分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.15%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Geovax Labs Inc C/Wts 29/09/2025、Nls Pharmaceutics Ltd.涨幅较大，Mustang Bio, Inc.、Geovax Labs, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为912.94%、856.05%、672.45%，振幅较大的相关个股有Nls Pharmaceutics Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Geovax Labs, Inc.，振幅分别为154.62%、134.50%、115.30%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619025052aef57cb6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240619025052aef57cb6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRBO","BK4202","OXM"],"gpt_icon":0},{"id":"2439986916","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439986916","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439986916?lang=zh_cn&edition=full","pubTime":"2024-05-31 22:59","pubTimestamp":1717167560,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日22时59分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.17%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Vaccinex, Inc.涨幅较大，Scisparc Ltd.、Bionomics Ltd Ads Each Rep 180 Ord Shs、Genprex, Inc.较为活跃，换手率分别为55.63%、30.39%、25.59%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Vaccinex, Inc.，振幅分别为79.44%、50.12%、49.42%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531225920941eb897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531225920941eb897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4202","BK4139","OXM"],"gpt_icon":0},{"id":"2439574439","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大跌6.47%报3.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2439574439","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439574439?lang=zh_cn&edition=full","pubTime":"2024-05-29 23:42","pubTimestamp":1716997352,"startTime":"0","endTime":"0","summary":"北京时间2024年05月29日23时42分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速跳水6.47%。截至发稿，该股报3.90美元/股，成交量4725股，换手率0.10%，振幅4.07%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529234232968108d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240529234232968108d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","NRBO","OXM","BK4139"],"gpt_icon":0},{"id":"2438374308","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨5.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2438374308","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2438374308?lang=zh_cn&edition=full","pubTime":"2024-05-28 21:58","pubTimestamp":1716904730,"startTime":"0","endTime":"0","summary":"北京时间2024年05月28日21时58分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.93%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.65%。其相关个股中，Insmed Incorporated、Calliditas Therapeutics Ab、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Exicure, Inc.、Mustang Bio, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为49.45%、12.55%、11.19%，振幅较大的相关个股有Exicure, Inc.、G1 Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为70.52%、21.76%、20.73%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052821585196810400&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024052821585196810400&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","OXM","BK4139","BK4202"],"gpt_icon":0},{"id":"2437205351","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.41%报4.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2437205351","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437205351?lang=zh_cn&edition=full","pubTime":"2024-05-24 22:00","pubTimestamp":1716559240,"startTime":"0","endTime":"0","summary":"北京时间2024年05月24日22时00分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.41%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Merus N.V.、Humacyte Inc C/Wts 27/08/2026 、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Verastem, Inc.、Finch Therapeutics Group, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为33.40%、14.73%、12.45%，振幅较大的相关个股有Nutriband Inc C/Wts 、Finch Therapeutics Group, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为34.71%、34.50%、32.50%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242200409680fa1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405242200409680fa1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4139","BK4202","OXM"],"gpt_icon":0},{"id":"2437591296","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437591296","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437591296?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:35","pubTimestamp":1716384953,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时35分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.24%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Engene Holdings Inc C/Wts 31/10/2028  Cl A、Rezolute, Inc.涨幅较大，Mustang Bio, Inc.、Biodexa Pharmaceuticals Plc、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为187.89%、95.58%、33.20%，振幅较大的相关个股有Prelude Therapeutics Incorporated、Rezolute, Inc.、Nutriband Inc C/Wts ，振幅分别为13.61%、13.00%、12.90%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213553aef1177f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213553aef1177f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","NRBO","OXM","BK4139"],"gpt_icon":0},{"id":"2437953267","title":"BUZZ-NeuroBo公司因肝脏治疗临床前数据良好而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2437953267","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437953267?lang=zh_cn&edition=full","pubTime":"2024-05-22 20:40","pubTimestamp":1716381656,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    5月22日 - ** NeuroBo制药公司  股价盘前上涨3%至4.72美元** 该公司称，临床前数据表明 (link)，其药物DA-1241与诺和诺德的  减肥药Wegovy联合使用，与单独使用其中一种疗法相比，有助于减轻肝损伤** 在小鼠中测试了这种联合疗法，以治疗代谢功能相关性脂肪性肝炎患者的肝组织瘢痕(MASH)** MASH，以前称为非酒精性脂肪性肝炎，约有 5%的美国人患有此病。** 截至上次收盘，股价累计上涨 23.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRBO","BK4139","BUZZ"],"gpt_icon":0},{"id":"2433722429","title":"NeuroBo Pharmaceuticals(NRBO.US)获Maxim Group首次覆盖，给予买入评级, 目标价10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2433722429","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433722429?lang=zh_cn&edition=full","pubTime":"2024-05-08 22:16","pubTimestamp":1715177818,"startTime":"0","endTime":"0","summary":"NeuroBo Pharmaceuticals(NRBO.US)获Maxim Group首次覆盖，给予买入评级, 目标价10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050822170087e0af14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050822170087e0af14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO"],"gpt_icon":0},{"id":"2433785230","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.26%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433785230","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433785230?lang=zh_cn&edition=full","pubTime":"2024-05-07 22:24","pubTimestamp":1715091841,"startTime":"0","endTime":"0","summary":"北京时间2024年05月07日22时24分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.26%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Lexaria Bioscience Corp C/Wts 14/01/2026 、Geovax Labs Inc C/Wts 29/09/2025、珐博进涨幅较大，Clearmind Medicine Inc.、Tc Biopharm  Plc、Allarity Therapeutics, Inc.较为活跃，换手率分别为1365.25%、163.95%、140.04%，振幅较大的相关个股有Clearmind Medicine Inc.、Tc Biopharm  Plc、Corvus Pharmaceuticals, Inc.，振幅分别为37.61%、37.16%、26.70%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722240187dcbcba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050722240187dcbcba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OXM","BK4202","NRBO"],"gpt_icon":0},{"id":"2432305156","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨5.26%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432305156","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432305156?lang=zh_cn&edition=full","pubTime":"2024-05-01 01:06","pubTimestamp":1714496785,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日01时06分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.26%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Eliem Therapeutics, Inc、Protagenic Therapeutics Inc C/Wts 29/04/2026 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1452.72%、231.33%、27.46%，振幅较大的相关个股有Eliem Therapeutics, Inc、Lexaria Bioscience Corp C/Wts 14/01/2026 、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为55.38%、48.00%、46.79%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010106257a57c9cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405010106257a57c9cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","NRBO","OXM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurobopharma.com","stockEarnings":[{"period":"1week","weight":-0.098},{"period":"1month","weight":0.1745},{"period":"3month","weight":0.3383},{"period":"6month","weight":0.3544},{"period":"1year","weight":0.1557},{"period":"ytd","weight":0.22}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroBo Pharmaceuticals, Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。NeuroBo Pharmaceuticals, Inc.是一家临床阶段的生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新药物。NeuroBo有两个主要项目，重点治疗非酒精性脂肪性肝炎（NASH）、肥胖症和2型糖尿病（T2D）。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.101843},{"month":2,"riseRate":0.375,"avgChangeRate":0.080599},{"month":3,"riseRate":0.5,"avgChangeRate":-0.020088},{"month":4,"riseRate":0.375,"avgChangeRate":-0.098642},{"month":5,"riseRate":0.25,"avgChangeRate":-0.104755},{"month":6,"riseRate":0.625,"avgChangeRate":0.103229},{"month":7,"riseRate":0.25,"avgChangeRate":-0.011052},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.23779},{"month":9,"riseRate":0.375,"avgChangeRate":0.039055},{"month":10,"riseRate":0.125,"avgChangeRate":-0.215957},{"month":11,"riseRate":0.375,"avgChangeRate":-0.112459},{"month":12,"riseRate":0.125,"avgChangeRate":-0.172588}],"exchange":"NASDAQ","name":"NeuroBo Pharmaceuticals, Inc.","nameEN":"NeuroBo Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeuroBo Pharmaceuticals, Inc.,NRBO,NeuroBo Pharmaceuticals, Inc.股票,NeuroBo Pharmaceuticals, Inc.股票老虎,NeuroBo Pharmaceuticals, Inc.股票老虎国际,NeuroBo Pharmaceuticals, Inc.行情,NeuroBo Pharmaceuticals, Inc.股票行情,NeuroBo Pharmaceuticals, Inc.股价,NeuroBo Pharmaceuticals, Inc.股市,NeuroBo Pharmaceuticals, Inc.股票价格,NeuroBo Pharmaceuticals, Inc.股票交易,NeuroBo Pharmaceuticals, Inc.股票购买,NeuroBo Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}